A recent study found that among people who were overweight or obese, taking metformin during a COVID infection reduced the risk of developing long COVID by 40%.
Adam Wheatley, The University of Melbourne et Jennifer Juno, The Peter Doherty Institute for Infection and Immunity
Firstly, there is no such thing as ‘too much’ immunity. Beyond the regular side-effects of a vaccine, there are no known additional risks to being re-vaccinated soon after an infection.
With the emergency phase of the COVID-19 pandemic in the rearview mirror, at least for now, we look back on a handful of stories that provided sharp insights at key moments in the pandemic.
People with long COVID report that their symptoms are dismissed or not treated seriously by health-care providers. This medical gaslighting not only prevents treatment but can cause stigma and shame.
Many people with long COVID experience persistent debilitating symptoms like fatigue and brain fog. But a few develop more life-threatening and lasting damage to their heart and brain.
Parsing the risk of myocarditis from viral infection versus vaccination is challenging, and researchers are intensely studying the various factors that are at play.
New Zealand’s initial elimination approach to COVID has significantly decreased the risk of hospitalisation and death. Now we need to find the right mix of measures to limit infection and reinfection.
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW Sydney